Skip over navigation
Banner
Directory
Directory Search
Jobs
Job Search Post a Job
Patient
Patient Resources Drug Development
History
Genealogy
Toons & Teasers
Industry
 Directory
 Toons & Teasers
Quick Links
 Directory
 Job Search
 Toons & Teasers
 Advertising
 
Facilities
 

EquipNet Auction: Sell Your Surplus Equipment on Our Global Marketplace Now!

Our Newest Cartoon Illustrates: "The Biology of Valentines"


Washington Life Science Industry Directory

EquipNet Auction: Looking to sell your pre-owned equipment? Sell it Now!

Banner Advertising

Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and delayed by COVID-19, to be launched in 2023 replacing WashingtonLifeScience.com. Regrettably, we are working with reduced staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved directory upon the launch of the new site. We apologize for the inconvenience.

Accelerator Corporation


Accelerator Corporation
1616 Eastlake Ave. E, Suite 200
Seattle, WA 98102
Accelerator Corporation
 
Phone: (206) 957-7300
Fax: (206) 957-7399
Year Established:  2003
Employees: 6
Main Contact: Thong Q. Le, CEO
 
Other Contacts:  Jessica Burback, Director, Operations
David McElligott, Ph.D., CSO
Dave Schubert, COO
Lindsay Rayle, CFO
 
Company Description

Accelerator is a vehicle for disciplined and efficient investment in and management of emerging biotechnology opportunities. The company identifies, evaluates, finances, and manages ground breaking emerging life sciences opportunities. The company has established and built a largely proprietary array of sources of deal flow, as well as a key set of resources to bring to bear in the development of the best opportunities emerging from those sources. These key resources, provided by Accelerator and its Affiliates – Amgen Ventures, ARCH Venture Partners, OVP Venture Partners, PPD, Inc., WRF Capital, Alexandria Real Estate Equities, Inc., and the Institute for Systems Biology – include committed investment capital, state-of-the-art facilities, world-class scientific and technical expertise and support, and experienced start-up management.

In the past six years, ten companies have been invested in through Accelerator. Three have emerged and raised follow on financings of more than $114 million. Five remain under management at Accelerator, having raised between them $15.7 million in initial Accelerator-based investments. In all, Accelerator companies have raised in excess of $143.5 million in initial and follow-on financings.

Accelerator’s investors have committed an additional $22.5 million to enable Accelerator to continue to identify, capitalize, and develop the next-generation of exciting emerging biotechnologies.

Accelerator Corporation relies upon a unique set of sources to fill a world-class pipeline of deal flow and has established and utilized a now proven array of resources to identify, evaluate, capitalize and manage emerging biotechnology companies. Accelerator provides this unprecedented collection of resources via a partnership between top-tiered investors, dedicated management, and a world-class research institute. These groups have come together because they recognize the potential of biotechnology both as an investment opportunity and as a critical component of the rapidly evolving future of medicine and healthcare. Moreover, these individuals and organizations have extensive experience in the difficult, complex and costly process of transforming an exciting laboratory discovery into a commercial product. By providing their expertise with companies in the Accelerator portfolio, these industry leaders provide critical knowledge and resources that can help to streamline the development and accelerate the commercialization of novel technologies.

Accelerator, through the global activities of its affiliates, has access to exciting new technologies and commercial opportunities developed at leading research institutions, universities and biotechnology companies around the world. This enables Accelerator to select only the most compelling investments from a deep pool of promising opportunities.



Main Industry Directory

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 1997 - 2023 Info.Resource, Inc. All rights reserved.
Privacy Policy . Cookie Policy . Terms of Use . About . Advertising

WashingtonLifeScience.com is owned and published by Info.Resource, Inc.